| P2093 | author name string | Zhu J | |
| | Shen R | |
| | Gong J | |
| | Pestell RG | |
| | Nanus DM | |
| | Schlegel PN | |
| | Goodman OB Jr | |
| P2860 | cites work | SIRT1 deacetylation and repression of p300 involves lysine residues 1020/1024 within the cell cycle regulatory domain 1 | Q24337470 |
| | Neuropeptide-induced androgen independence in prostate cancer cells: roles of nonreceptor tyrosine kinases Etk/Bmx, Src, and focal adhesion kinase | Q24746249 |
| | CREB-binding protein and p300 in transcriptional regulation | Q28209056 |
| | Tip60 and histone deacetylase 1 regulate androgen receptor activity through changes to the acetylation status of the receptor | Q28216750 |
| | Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism | Q28256059 |
| | Nuclear receptor coregulators: cellular and molecular biology | Q29547588 |
| | Androgen receptor phosphorylation. Regulation and identification of the phosphorylation sites | Q30309352 |
| | p300 and CBP: partners for life and death | Q33738453 |
| | Prostate cancer: molecular biology of early progression to androgen independence. | Q33871581 |
| | p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation | Q33899255 |
| | Androgen receptor (AR) coregulators: an overview | Q34123041 |
| | Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function | Q34125103 |
| | Acetylation of androgen receptor enhances coactivator binding and promotes prostate cancer cell growth | Q34276051 |
| | The androgen receptor acetylation site regulates cAMP and AKT but not ERK-induced activity. | Q34318315 |
| | Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities | Q34386388 |
| | Androgen receptors in prostate cancer | Q34866937 |
| | Acetylation in hormone signaling and the cell cycle | Q35027641 |
| | Acetylation of nuclear receptors in cellular growth and apoptosis | Q35864071 |
| | Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification | Q36740819 |
| | Identification and characterization of two androgen response regions in the human neutral endopeptidase gene | Q38304514 |
| | Disease-related potential of mutations in transcriptional cofactors CREB-binding protein and p300 in leukemias | Q38337719 |
| | p300 modulates nuclear morphology in prostate cancer | Q39707658 |
| | Recruitment of p300 by C/EBPbeta triggers phosphorylation of p300 and modulates coactivator activity | Q39714611 |
| | Phosphorylation of estrogen receptor alpha blocks its acetylation and regulates estrogen sensitivity. | Q40479849 |
| | Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. | Q40525923 |
| | Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling | Q40736037 |
| | Inhibition of histone acetyltransferase function of p300 by PKCdelta. | Q44179127 |
| | Absence of p300 gene promoter methylation in acute leukemia. | Q47812838 |
| | Bombesin stimulates the motility of human prostate-carcinoma cells through tyrosine phosphorylation of focal adhesion kinase and of integrin-associated proteins. | Q52526626 |
| | Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. | Q55033361 |
| | Mutations truncating the EP300 acetylase in human cancers | Q57888722 |
| | Bombesin stimulates growth of human prostatic cancer cells in vitro | Q69337614 |
| | Phosphorylation of p300 at serine 89 by protein kinase C | Q73044905 |
| | Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression | Q74033290 |
| | Phorbol ester causes ligand-independent activation of the androgen receptor | Q77437102 |
| | Selective activation of the probasin androgen-responsive region by steroid hormones | Q77796293 |
| | p300 regulates androgen receptor-independent expression of prostate-specific antigen in prostate cancer cells treated chronically with interleukin-6 | Q95814629 |
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 2011-2021 | |
| P577 | publication date | 2006-03-01 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells | |
| P478 | volume | 25 | |